CARMAT (ALCAR.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALCAR - FR0010907956 - Common Stock
ALCAR.PA Key Statistics, Chart & Performance
The current stock price of ALCAR.PA is 0.099 EUR. In the past month the price decreased by -43.69%. In the past year, price decreased by -94.18%.
ALCAR.PA Technical Analysis
ALCAR.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALCAR.PA. Both the profitability and financial health of ALCAR.PA have multiple concerns.
ALCAR.PA Financial Highlights
Over the last trailing twelve months ALCAR.PA reported a non-GAAP Earnings per Share(EPS) of -1.21. The EPS increased by 44.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -121.13% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALCAR.PA Forecast & Estimates
11 analysts have analysed ALCAR.PA and the average price target is 5.1 EUR. This implies a price increase of 5051.52% is expected in the next year compared to the current price of 0.099.
For the next year, analysts expect an EPS growth of 53.31% and a revenue growth 103.62% for ALCAR.PA
ALCAR.PA Ownership
About ALCAR.PA
Company Profile
Carmat SA is a medtech that designs, manufactures and markets the Aeson artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 153 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. The company specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Company Info
CARMAT
36, avenue de l'Europe
Velizy-Villacoublay ILE-DE-FRANCE FR
Employees: 162
Phone: 33139456450
CARMAT / ALCAR.PA FAQ
What does CARMAT do?
Carmat SA is a medtech that designs, manufactures and markets the Aeson artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 153 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. The company specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
What is the current price of ALCAR stock?
The current stock price of ALCAR.PA is 0.099 EUR. The price decreased by -1% in the last trading session.
Does ALCAR stock pay dividends?
ALCAR.PA does not pay a dividend.
How is the ChartMill rating for CARMAT?
ALCAR.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting ALCAR stock to perform?
11 analysts have analysed ALCAR.PA and the average price target is 5.1 EUR. This implies a price increase of 5051.52% is expected in the next year compared to the current price of 0.099.
Can you provide the market cap for CARMAT?
CARMAT (ALCAR.PA) has a market capitalization of 6.35M EUR. This makes ALCAR.PA a Nano Cap stock.
What is the next earnings date for ALCAR stock?
CARMAT (ALCAR.PA) will report earnings on 2025-10-31.